De Felipe M C, Molinero M T, Del Río J
Department of Neuropharmacology, Cajal Institute, CSIC, Madrid, Spain.
Brain Res. 1989 Apr 24;485(2):301-8. doi: 10.1016/0006-8993(89)90574-x.
Substance P (SP) antiserum was administered to rats on the second day of life. Three months later, the content of SP was significantly decreased in the dorsal part of the spinal cord and in the periaqueductal gray matter of these animals, as compared to control rats receiving a neonatal treatment of non-specific immunoglobulins. Further, the levels of Met-enkephalin and 5-hydroxyindole acetic acid (5-HIAA) were concomitantly increased in the same regions. SP receptor binding sites and opioid receptors, which appear earlier in development, were not modified in the two regions studied. On the other hand, the antinociceptive response to intracerebroventricular (i.c.v.) injection of SP or of the synthetic enkephalin analog D-Ala2,D-Leu5-enkephalin, as well as the hypertensive response to i.c.v. SP were blocked. The results suggest that, after administration to newborn rats, the antiserum is able to penetrate into SP neurons, producing a long-lasting SP suppression and a subsensitivity to the pharmacological effects of the neuropeptide. The modifications in the content of Met-enkephalin and 5-HIAA are possibly compensatory changes which subserve the functionality of central cardiovascular and pain regulatory systems after the immunolesion.
出生第二天给大鼠注射P物质(SP)抗血清。三个月后,与接受新生儿非特异性免疫球蛋白治疗的对照大鼠相比,这些动物脊髓背侧和导水管周围灰质中的SP含量显著降低。此外,同一区域的甲硫氨酸脑啡肽和5-羟色胺酸(5-HIAA)水平同时升高。发育中较早出现的SP受体结合位点和阿片受体在研究的两个区域未发生改变。另一方面,对脑室内(i.c.v.)注射SP或合成脑啡肽类似物D-Ala2,D-Leu5-脑啡肽的抗伤害感受反应以及对i.c.v. SP的高血压反应均被阻断。结果表明,给新生大鼠注射抗血清后,抗血清能够穿透进入SP神经元,产生持久的SP抑制以及对该神经肽药理作用的敏感性降低。甲硫氨酸脑啡肽和5-HIAA含量的改变可能是免疫损伤后为维持中枢心血管和疼痛调节系统功能而产生的代偿性变化。